Leuko is developing PointCheck™, the first device for non-invasive white blood cell monitoring. This portable device allows for fast and simple assessment of white blood cell levels without the need for blood draws, aiming to improve the quality of life for immunosuppressed patients.

Leuko is developing PointCheck™, the first device for non-invasive white blood cell monitoring. This portable device allows for fast and simple assessment of white blood cell levels without the need for blood draws, aiming to improve the quality of life for immunosuppressed patients.